Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03267316
Title A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors (CANFOUR)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Cantargia AB
Indications

lung squamous cell carcinoma

lung non-squamous non-small cell carcinoma

Therapies

Nidanilimab

Cisplatin + Gemcitabine + Nidanilimab

Gemcitabine + Nab-paclitaxel + Nidanilimab

Age Groups: adult | senior
Covered Countries ESP | DEU | BEL | AUT

Additional content available in CKB BOOST